South Africa
Feb 1, 2021
Article and Study Summary Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study Published in: Lancet. 2020;396 (10267):1994-2005...
Dec 17, 2020
Angela M Bengtson, Tamsin K Phillips, Stanzi M le Roux, Kirsty Brittain, Allison Zerbe, Hlengiwe P Madlala, Thokozile R Malaba, Gregory Petro, Elaine J Abrams, Landon Myer PMID: 33285444 DOI: 10.1016/j.preghy.2020.11.005 Abstract Objective:Â To examine associations...
Nov 19, 2020
Deese J, Philip N, Lind M, Ahmed K, Batting J,Beksinska M, Edward V A, Louw C E, Onono M, Palanee-Phillips T, Smit J A, Baeten J M, Donnell D, Mastro T D, Mugo N R, Nanda K, Rees H, Morrison C Abstract Objectives: Reproductive aged women are at risk of pregnancy and...
Nov 18, 2020
Article and Study Summary: Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial. Published in: Lancet Glob Health. 2020;8(10):e1305-e1315....
Jul 24, 2020
Mukandavire Z, Nyabadza F, Malunguza NJ, Cuadros DF, Shiri T, Musuka G (2020) PLoS ONE 15(7): e0236003. https://doi.org/10.1371/journal.pone.0236003 Abstract The emergence and fast global spread of COVID-19 has presented one of the greatest public health...